Dunlop Review welcome but “misses a crucial opportunity to recommend a fully independent process”
National Officer for Scotland Allan Sampson has said the FDA “broadly supports” the recommendations of Laura Dunlop QC’s review into the Scottish Government’s handling of harassment complaints but criticised the report for missing “a crucial opportunity to recommend a fully independent process for handling all complaints against ministers and former ministers”.
Dunlop was commissioned by the Scottish Government to conduct the review, following the concession of the judicial review brought by former First Minister Alex Salmond on the handling of harassment complaints made against him.
In her report, Dunlop makes 10 recommendations on how to improve the complaints process. Sampson said the conclusions that “complaints of sexual harassment should face no time bar, that former ministers should remain subject to the procedure and that the current policies should be merged for clarity” were” “particularly welcome”.
However, he cautioned that these recommendations “will require further consideration as to how these can be integrated in to the current procedures” and highlighted that only a fully independent process would win the confidence of both ministers and civil servants.
“Her report… seeks to make a distinction between the necessity for independence related to former ministers without addressing the inherent conflicts and weaknesses in relation to serving ministers, which have been brutally exposed by the events of the last three years,” he explained. “A fully independent process to deal with complaints against both former and current ministers will provide confidence to civil servants and ministers alike that any complaint would be determined by merit alone, free from accusations of a ‘cover up’ or ‘conspiracy’ that have been thrown around with abandon in recent months.”
Sampson added that confidence in the procedure of handling complaints against ministers “needs to be urgently restored” and this can only be achieved if “independence, clarity and transparency” are established.
Related News
-
“Significant victory” for FDA members: MPs vote to introduce risk-based exclusion at the point of arrest
FDA welcomes MPs vote to introduce a formal mechanism to risk assess any MP at the point of arrest.
-
FDA calls on Senedd to implement “fully independent process for dealing with complaints of bullying, harassment and sexual harassment”
FDA Cymru|Wales has called on the Senedd to “implement a fully independent process for dealing with complaints of bullying, harassment and sexual harassment” made against MSs.
-
Announcement on risk-based exclusion in Parliament a “significant victory”, says FDA
Updated proposals on a risk-based exclusion policy in Parliament from the House of Commons Commission are a “significant victory” for the FDA and should now be implemented without delay.